Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817)

Persistence and Adherence during the First Six Months of Tocilizumab Treatment Among Rheumatoid Arthritis Patients in Routine Clinical Practice in Greece. Results from the Single Arm REMISSION II Study (NCT01649817)

Objective/Aim: One of the most important factors that affect a treatment’s performance in rheumatoid arthritis (RA) is adherence to medications. According to literature, there are several reasons for non-adherence in RA patients with some of them being related to a specific patient profile of the st...

Full description

Bibliographic Details
Main Authors: Theodora E. Markatseli, Athina Theodoridou, Marina Zakalka, Eftychia Koukli, Eva Triantafyllidou, Sotiris Tsalavos, Alexandros Andrianakos, Alexandros A. Drosos
Format: Article
Language:English
Published: PCO Convin S.A. 2019-01-01
Series:Mediterranean Journal of Rheumatology
Subjects:
rheumatoid arthritis
tocilizumab
clinical practice
private practice
Greece
Online Access:http://www.mjrheum.org/assets/files/792/file188_740.pdf

Internet

http://www.mjrheum.org/assets/files/792/file188_740.pdf

Similar Items